Parallel Advisors’s Gossamer Bio GOSS Stock Holding History

Parallel Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-929	Closed	-$9K	–	2544
2020 Q1	$9K	Buy	+929	New	+$12.1K	﹤0.01%	1648

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Parallel Advisors's GOSS Position: Q2 2020 in Review

Parallel Advisors sold out of Gossamer Bio (GOSS) in Q2 2020, closing a stake of 929 shares — an estimated $9K sold.

Parallel Advisors first reported a position in GOSS in Q1 2020 and held it in 1 quarter. The position peaked at $9K in Q1 2020. 110 funds tracked by Wall St. Rank hold GOSS as of Q2 2020.

Parallel Advisors reported no remaining Gossamer Bio position as of Q2 2020 after selling out during the quarter.
Parallel Advisors sold 929 Gossamer Bio shares in Q2 2020, an estimated $9K.
Parallel Advisors first reported a position in Gossamer Bio in Q1 2020 and held it in 1 quarter.
Parallel Advisors's Gossamer Bio position peaked at $9K in Q1 2020.
110 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2020.

Based on Parallel Advisors's 13F filing for Q2 2020, filed 16 Jul 2020.